FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2121103313> ?p ?o ?g. }

• W2121103313 endingPage "666" @default.
• W2121103313 startingPage "661" @default.
• W2121103313 abstract "To investigate whether 4-month preoperative lanreotide treatment would improve the surgical cure rate of newly diagnosed acromegalic patients with macroadenomas.A prospective, randomised study.After a baseline evaluation, patients were randomly assigned to 4-month preoperative treatment with lanreotide (starting with 30 mg/2 weeks i.m. and increasing to 30 mg/week i.m. at week 8 if mean GH >2.5 microg/l on GH day curves; pretreatment group, Group 1) or to transsphenoidal surgery (direct surgery group, Group 2). Cure was evaluated 4 months postoperatively primarily by fasting IGF1 less than or equal to age-adjusted upper limit of normal.A pool of 108 patients was randomly divided into two groups. Five patients in each group were lost to follow-up during the study period, so 49 patients in each group were analysed. At baseline, no difference was observed between the two groups. Cure was established in 24 of 49 (49.0%, 95% confidence interval (CI), 35.0-63.0%) pretreated patients (Group 1) versus 9 of 49 (18.4%, 95% CI, 7.6-29.2%) direct surgery patients (Group 2; P=0.001). Surgical morbidity was recorded in 12 patients (12.2%) and was similar in Group 1 and 2 patients (14.3 and 10.2% respectively; P=0.538). The postoperative hospital stay was similar between groups: being 4.5+/-1.6 days in Group 1 vs 4.8+/-1.9 days in Group 2 (P=0.328).Pretreatment with lanreotide before transsphenoidal surgery improves surgical cure rates in patients with GH-secreting pituitary macroadenomas. Pretreatment does not affect surgical complications or duration of hospital stay (ClinicalTrials.gov number, NCT00993356)." @default.
• W2121103313 created "2016-06-24" @default.
• W2121103313 creator A5009518393 @default.
• W2121103313 creator A5025261931 @default.
• W2121103313 creator A5039427365 @default.
• W2121103313 creator A5045338371 @default.
• W2121103313 creator A5046252842 @default.
• W2121103313 creator A5048186115 @default.
• W2121103313 creator A5059665113 @default.
• W2121103313 creator A5084133336 @default.
• W2121103313 creator A5085297965 @default.
• W2121103313 date "2010-04-01" @default.
• W2121103313 modified "2023-10-12" @default.
• W2121103313 title "Preoperative lanreotide treatment in acromegalic patients with macroadenomas increases short-term postoperative cure rates: a prospective, randomised trial" @default.
• W2121103313 cites W123434114 @default.
• W2121103313 cites W1544880251 @default.
• W2121103313 cites W1967074705 @default.
• W2121103313 cites W1979105743 @default.
• W2121103313 cites W1991182479 @default.
• W2121103313 cites W2014729851 @default.
• W2121103313 cites W2022401782 @default.
• W2121103313 cites W2027321168 @default.
• W2121103313 cites W2028425454 @default.
• W2121103313 cites W2040054585 @default.
• W2121103313 cites W2042254456 @default.
• W2121103313 cites W2056297943 @default.
• W2121103313 cites W2057277019 @default.
• W2121103313 cites W2072997411 @default.
• W2121103313 cites W2075286309 @default.
• W2121103313 cites W2081324142 @default.
• W2121103313 cites W2084067269 @default.
• W2121103313 cites W2084898691 @default.
• W2121103313 cites W2118341413 @default.
• W2121103313 cites W2148634043 @default.
• W2121103313 cites W2157737658 @default.
• W2121103313 cites W2171368332 @default.
• W2121103313 cites W2242576968 @default.
• W2121103313 cites W4230251289 @default.
• W2121103313 cites W4240145225 @default.
• W2121103313 cites W4243739115 @default.
• W2121103313 cites W4245187423 @default.
• W2121103313 cites W4254140161 @default.
• W2121103313 doi "https://doi.org/10.1530/eje-09-0908" @default.
• W2121103313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20061334" @default.
• W2121103313 hasPublicationYear "2010" @default.
• W2121103313 type Work @default.
• W2121103313 sameAs 2121103313 @default.
• W2121103313 citedByCount "93" @default.
• W2121103313 countsByYear W21211033132012 @default.
• W2121103313 countsByYear W21211033132013 @default.
• W2121103313 countsByYear W21211033132014 @default.
• W2121103313 countsByYear W21211033132015 @default.
• W2121103313 countsByYear W21211033132016 @default.
• W2121103313 countsByYear W21211033132017 @default.
• W2121103313 countsByYear W21211033132018 @default.
• W2121103313 countsByYear W21211033132019 @default.
• W2121103313 countsByYear W21211033132020 @default.
• W2121103313 countsByYear W21211033132021 @default.
• W2121103313 countsByYear W21211033132022 @default.
• W2121103313 crossrefType "journal-article" @default.
• W2121103313 hasAuthorship W2121103313A5009518393 @default.
• W2121103313 hasAuthorship W2121103313A5025261931 @default.
• W2121103313 hasAuthorship W2121103313A5039427365 @default.
• W2121103313 hasAuthorship W2121103313A5045338371 @default.
• W2121103313 hasAuthorship W2121103313A5046252842 @default.
• W2121103313 hasAuthorship W2121103313A5048186115 @default.
• W2121103313 hasAuthorship W2121103313A5059665113 @default.
• W2121103313 hasAuthorship W2121103313A5084133336 @default.
• W2121103313 hasAuthorship W2121103313A5085297965 @default.
• W2121103313 hasBestOaLocation W21211033131 @default.
• W2121103313 hasConcept C126322002 @default.
• W2121103313 hasConcept C141071460 @default.
• W2121103313 hasConcept C168563851 @default.
• W2121103313 hasConcept C188816634 @default.
• W2121103313 hasConcept C2777428134 @default.
• W2121103313 hasConcept C2777433750 @default.
• W2121103313 hasConcept C2777785397 @default.
• W2121103313 hasConcept C2779318953 @default.
• W2121103313 hasConcept C2779609023 @default.
• W2121103313 hasConcept C2779653919 @default.
• W2121103313 hasConcept C2984496839 @default.
• W2121103313 hasConcept C44249647 @default.
• W2121103313 hasConcept C71315377 @default.
• W2121103313 hasConcept C71924100 @default.
• W2121103313 hasConceptScore W2121103313C126322002 @default.
• W2121103313 hasConceptScore W2121103313C141071460 @default.
• W2121103313 hasConceptScore W2121103313C168563851 @default.
• W2121103313 hasConceptScore W2121103313C188816634 @default.
• W2121103313 hasConceptScore W2121103313C2777428134 @default.
• W2121103313 hasConceptScore W2121103313C2777433750 @default.
• W2121103313 hasConceptScore W2121103313C2777785397 @default.
• W2121103313 hasConceptScore W2121103313C2779318953 @default.
• W2121103313 hasConceptScore W2121103313C2779609023 @default.
• W2121103313 hasConceptScore W2121103313C2779653919 @default.
• W2121103313 hasConceptScore W2121103313C2984496839 @default.
• W2121103313 hasConceptScore W2121103313C44249647 @default.
• W2121103313 hasConceptScore W2121103313C71315377 @default.
• W2121103313 hasConceptScore W2121103313C71924100 @default.

• next